Article: Is intensive LDL-cholesterol lowering beneficial and safe?
| Title | Is intensive LDL-cholesterol lowering beneficial and safe? |
|---|---|
| Authors | Cheung, BM1 Lam, KS1 |
| Issue Date | 2010 |
| Publisher | The Lancet Publishing Group. The Journal's web site is located at http://www.elsevier.com/locate/lancet |
| Citation | The Lancet, 2010, v. 376 n. 9753, p. 1622-1624 [How to Cite?] DOI: http://dx.doi.org/10.1016/S0140-6736(10)61545-0 |
| ISSN | 0140-6736 2011 Impact Factor: 38.278 2011 SCImago Journal Rankings: 1.486 |
| DOI | http://dx.doi.org/10.1016/S0140-6736(10)61545-0 |
| ISI Accession Number ID | WOS:000284451000006 |
| References | References in Scopus |
| dc.contributor.author | Cheung, BM |
|---|---|
| dc.contributor.author | Lam, KS |
| dc.date.accessioned | 2010-12-23T08:34:45Z |
| dc.date.available | 2010-12-23T08:34:45Z |
| dc.date.issued | 2010 |
| dc.description.nature | Link_to_subscribed_fulltext |
| dc.identifier.citation | The Lancet, 2010, v. 376 n. 9753, p. 1622-1624 [How to Cite?] DOI: http://dx.doi.org/10.1016/S0140-6736(10)61545-0 |
| dc.identifier.citeulike | 8235640 |
| dc.identifier.doi | http://dx.doi.org/10.1016/S0140-6736(10)61545-0 |
| dc.identifier.epage | 1624 |
| dc.identifier.hkuros | 183468 |
| dc.identifier.isi | WOS:000284451000006 |
| dc.identifier.issn | 0140-6736 2011 Impact Factor: 38.278 2011 SCImago Journal Rankings: 1.486 |
| dc.identifier.issue | 9753 |
| dc.identifier.pmid | 21067806 |
| dc.identifier.scopus | eid_2-s2.0-78449279309 |
| dc.identifier.spage | 1622 |
| dc.identifier.uri | http://hdl.handle.net/10722/129290 |
| dc.identifier.volume | 376 |
| dc.language | eng |
| dc.publisher | The Lancet Publishing Group. The Journal's web site is located at http://www.elsevier.com/locate/lancet |
| dc.publisher.place | United Kingdom |
| dc.relation.ispartof | The Lancet |
| dc.relation.references | References in Scopus |
| dc.subject.mesh | Anticholesteremic Agents - administration & dosage - adverse effects |
| dc.subject.mesh | Cardiovascular Diseases - prevention & control |
| dc.subject.mesh | Cholesterol, LDL - blood |
| dc.subject.mesh | Humans |
| dc.subject.mesh | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage - adverse effects |
| dc.subject.mesh | Hypercholesterolemia - drug therapy |
| dc.subject.mesh | Risk Reduction Behavior |
| dc.subject.mesh | Simvastatin - administration & dosage - adverse effects |
| dc.title | Is intensive LDL-cholesterol lowering beneficial and safe? |
| dc.type | Article |
Author Affiliations
- The University of Hong Kong

